R-5780, an oral immuno-oncology drug designed to activate gut-regulated immune pathways, will now be evaluated in a phase 1 ...

Fig 1. Summary of systemic therapy for stage I-III anal SSC recommendations. C, conditional; CRT, chemoradiotherapy; ECOG PS, Eastern Cooperative Oncology Group ...

Squamous cell carcinoma (SCC) is the second most common ... When doctors diagnose melanoma in the early stages, the survival rate is as high as 99%. In the late stages, the survival rate falls ...

Pathologic Complete Response reported for 2 patients with cutaneous Squamous Cell Carcinoma Marlborough, ...

Petticoat cancer develops around the waistline in individuals who wear tightly tied saree underskirts (petticoats) or dhotis.

Calcipotriol-plus–5-FU therapy activates immune pathways, offering long-lasting protection against squamous cell carcinoma by ...

Shares of Phio Pharmaceuticals Corp. surged 330% Monday afternoon, reaching their highest levels in nearly eight months, to ...

The NSCLC pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical ...